Literature DB >> 11259753

Chronic intrathecal morphine administration produces homologous mu receptor/G-protein desensitization specifically in spinal cord.

C E Maher1, J C Eisenach, H L Pan, R Xiao, S R Childers.   

Abstract

Previous studies have shown that chronic i.v. treatment with morphine or heroin decreased mu opioid receptor activation of G-proteins in specific brain regions. The present study examined the effect of intrathecal (i.t.) morphine administration on receptor/G-protein coupling in the spinal cord. In spinal cord membranes, [35S]GTP gamma S binding was stimulated by agonists of several G-protein-coupled receptors, including mu opioid (DAMGO), delta opioid (DPDPE), GABA(B) (baclofen), cannabinoid CB(1) (WIN 55,212-2), muscarinic cholinergic (carbachol) and adenosine A(1) (PIA). [35S]GTP gamma S autoradiography revealed that most of this agonist activation of G-proteins was localized to laminae I and II of dorsal horn. To determine the effects of chronic morphine on these receptor activities, rats were treated for 7 days with 0.11 mg/kg/day i.t. morphine, and receptor activation of G-proteins was determined by [35S]GTP gamma S autoradiography of brain and spinal cord. In spinal cord sections, chronic morphine treatment decreased DAMGO-stimulated [35S]GTP gamma S binding in laminae I and II at all levels of spinal cord examined. There were no effects of morphine treatment on [35S]GTP gamma S stimulation in spinal cord by other receptor systems examined (Adenosine A(1) and GABA(B)), and no significant effects of chronic i.t. morphine treatment were observed in brain sections. These data show that homologous desensitization of mu receptor/G-protein coupling occurs specifically in spinal cord following chronic morphine administration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259753     DOI: 10.1016/s0006-8993(00)03093-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Chronic baclofen desensitizes GABA(B)-mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain.

Authors:  Bradley M T Keegan; Thomas J R Beveridge; Jeffrey J Pezor; Ruoyu Xiao; Tammy Sexton; Steven R Childers; Allyn C Howlett
Journal:  Neuropharmacology       Date:  2015-02-25       Impact factor: 5.250

2.  Neuroadaptation of GABAergic transmission in the central amygdala during chronic morphine treatment.

Authors:  Michal Bajo; Marisa Roberto; Samuel G Madamba; George Robert Siggins
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

3.  Agonist-dependent attenuation of mu-opioid receptor-mediated G-protein activation in the dorsal root ganglia of neuropathic rats.

Authors:  Ilona Obara; Ozge Gunduz Cinar; Katarzyna Starowicz; Sandor Benyhe; Anna Borsodi; Barbara Przewlocka
Journal:  J Neural Transm (Vienna)       Date:  2010-03-06       Impact factor: 3.575

Review 4.  Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.

Authors:  Kirsten M Raehal; Cullen L Schmid; Chad E Groer; Laura M Bohn
Journal:  Pharmacol Rev       Date:  2011-08-26       Impact factor: 25.468

5.  Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons.

Authors:  S-R Chen; A Prunean; H-M Pan; K L Welker; H-L Pan
Journal:  Neuroscience       Date:  2007-01-17       Impact factor: 3.590

6.  Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance.

Authors:  L J Sim-Selley; K L Scoggins; M P Cassidy; L A Smith; W L Dewey; F L Smith; D E Selley
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

7.  Role of the guanine nucleotide binding protein, Gαo, in the development of morphine tolerance and dependence.

Authors:  Jennifer T Lamberts; Lisa D Rosenthal; Emily M Jutkiewicz; John R Traynor
Journal:  Psychopharmacology (Berl)       Date:  2017-10-03       Impact factor: 4.530

8.  Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.

Authors:  Paul A Smith; Dana E Selley; Laura J Sim-Selley; Sandra P Welch
Journal:  Eur J Pharmacol       Date:  2007-06-12       Impact factor: 4.432

9.  Can repeated exposure to morphine change the spinal analgesic effects of lidocaine in rats?

Authors:  Ali Dabbagh; Shervin Farkhondehkish Moghadam; Samira Rajaei; Zahra Mansouri; Homa Shardi Manaheji
Journal:  J Res Med Sci       Date:  2011-10       Impact factor: 1.852

10.  The effect of adjuvant midazolam compared with fentanyl on the duration of spinal anesthesia with 0.5% bupivacaine in opium abusers.

Authors:  Farhad Safari; Ali Dabbagh; Mansour Sharifnia
Journal:  Korean J Anesthesiol       Date:  2012-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.